Zobrazeno 1 - 10
of 509
pro vyhledávání: '"Enrico Girardi"'
Autor:
Silvia Meschi, Francesca Colavita, Fabrizio Carletti, Valentina Mazzotta, Giulia Matusali, Eliana Specchiarello, Tommaso Ascoli Bartoli, Annalisa Mondi, Claudia Minosse, Maria Letizia Giancola, Carmela Pinnetti, Maria Beatrice Valli, Daniele Lapa, Klizia Mizzoni, David J. Sullivan, Jiangda Ou, Daniele Focosi, Enrico Girardi, Emanuele Nicastri, Andrea Antinori, Fabrizio Maggi
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Since spring 2022, the global epidemiology of the monkeypox virus (MPXV) has changed. The unprecedented increase of human clade II MPXV cases worldwide heightened concerns about this emerging zoonotic disease. We analysed the positivity rate
Externí odkaz:
https://doaj.org/article/301cbc24a6104987b2c59f72c9fec841
Autor:
Maria Beatrice Valli, Maria Letizia Schiavone, Martina Rueca, Giulia Berno, Pietro Giorgio Spezia, Cesare Ernesto Maria Gruber, Federica Forbici, Lavinia Fabeni, Daniele Focosi, Enrico Girardi, Marcello Meledandri, Fabrizio Maggi
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 6 (2024)
Externí odkaz:
https://doaj.org/article/a08afea559ff4e90af0ce820c7b71749
Autor:
Alessandra D’Abramo, Francesco Rinaldi, Serena Vita, Riccardo Mazzieri, Angela Corpolongo, Claudia Palazzolo, Tommaso Ascoli Bartoli, Francesca Faraglia, Maria Letizia Giancola, Enrico Girardi, Emanuele Nicastri
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-7 (2024)
Abstract Background The aim of this study is to design ad hoc malaria learning (ML) approaches to predict clinical outcome in all patients with imported malaria and, therefore, to identify the best clinical setting. Methods This is a single-centre cr
Externí odkaz:
https://doaj.org/article/c06dc969a6314493963a5a990f2c4b7e
Autor:
Carmela Pinnetti, Annalisa Mondi, Valentina Mazzotta, Serena Vita, Fabrizio Carletti, Camilla Aguglia, Alessia Beccacece, Alessandra Vergori, Roberta Gagliardini, Eliana Specchiarello, Tommaso Ascoli Bartoli, Francesco Baldini, Maria Letizia Giancola, Maria Beatrice Valli, Alessandra D'Abramo, Saba Gebremeskel Teklè, Carla Fontana, Anna Rosa Garbuglia, Enrico Girardi, Fabrizio Maggi, Francesco Vaia, Emanuele Nicastri, Andrea Antinori
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 1, Pp 130-136 (2024)
During the 2022-outbreak, peculiar clinical presentations of Mpox have been described, some of which can make the diagnosis of the disease extremely challenging. Here we report a case series of fourteen patients with Mpox pharynogotonsillar involveme
Externí odkaz:
https://doaj.org/article/6ccbe39fe22d432fa02dd935cee58197
Autor:
Annalisa Mondi, Alessandro Cozzi-Lepri, Alessandro Tavelli, Antonella Cingolani, Andrea Giacomelli, Giancarlo Orofino, Gabriella De Girolamo, Carmela Pinnetti, Andrea Gori, Annalisa Saracino, Alessandra Bandera, Giulia Marchetti, Enrico Girardi, Cristina Mussini, Antonella d'Arminio Monforte, Andrea Antinori
Publikováno v:
International Journal of Infectious Diseases, Vol 142, Iss , Pp 106995- (2024)
Objectives: Limited data are available on the long-term outcomes in recent years for late HIV diagnosis (LD). Methods: All subjects with HIV enrolled in the ICONA cohort in 2009-2022 who started antiretroviral treatment (ART) within 4 months from dia
Externí odkaz:
https://doaj.org/article/35c48fd2f14a4981ae16004ca2d06964
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era
Autor:
Serena Vita, Emanuela Giombini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Investigation Team Spallanzani COVID-19 case
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
Abstract: Im We describe here a single-center case series of 27 IC COVID-19 inpatients (mostly with haematological disorders) treated with a combined therapy based on tixagevimab/cilgavimab (T/C) plus small-molecule antivirals (AV), between April 1 2
Externí odkaz:
https://doaj.org/article/30738854fff242a78d2283cc996ef5ee
Autor:
Federica Repele, Tonino Alonzi, Assunta Navarra, Chiara Farroni, Andrea Salmi, Gilda Cuzzi, Giovanni Delogu, Gina Gualano, Vincenzo Puro, Gabriella De Carli, Enrico Girardi, Fabrizio Palmieri, Adrian R. Martineau, Delia Goletti
Publikováno v:
International Journal of Infectious Diseases, Vol 141, Iss , Pp 106999- (2024)
Objectives: To investigate whether Mycobacterium tuberculosis (Mtb) DNA is detected in peripheral blood mononuclear cells (PBMC) of subjects with tuberculosis (TB) or TB infection (TBI) living in a low-burden country. Methods: We prospectively enroll
Externí odkaz:
https://doaj.org/article/9ee57b8cf62f4c5aab097632c57cd8ec
Autor:
Roberta Gagliardini, Andrea Giacomelli, Giorgio Bozzi, Antonella D'Arminio Monforte, Alessandro Tavelli, Valentina Mazzotta, Elena Bruzzesi, Adriana Cervo, Annalisa Saracino, Cristina Mussini, Enrico Girardi, Alessandro Cozzi-Lepri, Andrea Antinori
Publikováno v:
Travel Medicine and Infectious Disease, Vol 58, Iss , Pp 102691- (2024)
Background: COVID-19 pandemic challenged the UNAIDS 90-90-90 targets. How the COVID-19 pandemic affected HIV retention in care and whether it has disproportionally affected migrant people with HIV (PWH) remained to be investigated. Methods: PWH in IC
Externí odkaz:
https://doaj.org/article/d62b2d8bd9fa4359a1c7305bfe98ba54
Autor:
Alessandra Vergori, Giulia Matusali, Alessandro Cozzi Lepri, Eleonora Cimini, Marisa Fusto, Francesca Colavita, Roberta Gagliardini, Stefania Notari, Valentina Mazzotta, Davide Mariotti, Stefania Cicalini, Enrico Girardi, Francesco Vaia, Fabrizio Maggi, Andrea Antinori
Publikováno v:
International Journal of Infectious Diseases, Vol 134, Iss , Pp 195-199 (2023)
Objectives: To investigate immunogenicity of SARS-CoV-2 vaccine third booster dose (3BD; fifth dose) with bivalent vaccine original/BA4/5 vaccine in people living with HIV (PLWH). Methods: This is an observational cohort study to evaluate the outcome
Externí odkaz:
https://doaj.org/article/351a2d8456fe4ceab581805880010ba5
Autor:
Alessandra Vergori, Giulia Matusali, Eleonora Cimini, Licia Bordi, Paola Borrelli, Simone Lanini, Roberta Palazzi, Jessica Paulicelli, Davide Mariotti, Valentina Mazzotta, Stefania Notari, Rita Casetti, Massimo Francalancia, Silvia Rosati, Alessandra D’Abramo, Cosmina Mija, Paola Mencarini, Eugenia Milozzi, Emanuela Caraffa, Simona Sica, Elisabetta Metafuni, Federica Sorà, Angela Rago, Agostina Siniscalchi, Elisabetta Abruzzese, Mariagrazia Garzia, Giovanni Luzi, Roberta Battistini, Luca Prosperini, Antonella Cingolani, Enrico Girardi, Fabrizio Maggi, Andrea Antinori
Publikováno v:
Vaccines, Vol 12, Iss 7, p 784 (2024)
Objective. We aimed to report the real-world use and outcomes over time in immunocompromised individuals receiving tixagevimab/cilgavimab (T/C) pre-exposure prophylaxis (PrEP). Methods. This observational study included participants who received T/C
Externí odkaz:
https://doaj.org/article/a19aab91b3f7459c96a304c41503358a